Wall Street Analysts Have Consensus Hold Recommendation For Baxter International Inc. (BAX)

Looking up to 2026, the expert told investors successful a probe enactment that aesculapian exertion companies were well-placed, fixed the favorable inclination successful infirmary spending, cardinal merchandise launches, and debased banal valuations.

The accommodation follows Argus Research’s downgrading of Baxter International Inc. (NYSE:BAX) connected October 31, citing a important dividend reduction, effectual from January 2026, with the institution expecting the determination to thrust a $300 cardinal oregon higher boost successful yearly currency flow. These funds volition beryllium utilized to enactment de-leveraging efforts to fortify the equilibrium sheet.

Argus’ analysts besides expressed concerns astir the anemic outlook for the company’s IV fluid solutions business.

As of the adjacent of concern connected December 5, Wall Street analysts person a statement Hold standing for the stock, with a one-year mean stock terms people of $23.80, representing an upside imaginable of 28%.

Baxter International Inc. (NYSE:BAX) is simply a planetary aesculapian exertion institution offering a wide scope of healthcare products. The banal has had a challenging year, slumping 36% twelvemonth to date.

While we admit the imaginable of BAX arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 10 Best Drone Stocks to Buy Right Now and 8 Best Small-Cap Defense Stocks to Buy Right Now 

Disclosure: None.